We are live on ! Find out more
TPI

TIANYIN PHARMACEUTICAL
TPI

Delisted

TPI was delisted on the 29th of April, 2016.

Back to rankings

2 hedge funds and large institutions have $10K invested in TIANYIN PHARMACEUTICAL in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% less funds holding

Funds holding: 5 → 2 (-3)

97% less capital invested

Capital invested by funds: $297K → $10K (-$287K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-3
Holders Change %
-60%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$124K
2
UBS Group
UBS Group
Switzerland
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
1
California Public Employees Retirement System
California
$8K – – –
CHP
2
Cable Hill Partners
Oregon
$2K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
– -$124K -827,600 Closed
UBS Group
4
UBS Group
Switzerland
– -$1K -5,132 Closed

TPI Hedge Fund Activity: Q2 2016 in Review

2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q2 2016, worth a combined $10K — down 97% from $297K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TPI and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Renaissance Technologies, exiting entirely with an estimated $124K sold.

  • 2 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q2 2016, down from 5 in Q1 2016.
  • Funds reported $10K of TIANYIN PHARMACEUTICAL stock for Q2 2016, down 97% quarter-over-quarter.
  • 0 funds opened new TIANYIN PHARMACEUTICAL positions in Q2 2016 and 2 closed out, a net change of -2 holders.
  • The largest TIANYIN PHARMACEUTICAL seller in Q2 2016 was Renaissance Technologies, an estimated $124K sold.

Based on aggregated 13F filings for Q2 2016.